MSAM
Moloney Securities Asset Management’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $584K | Sell |
1,501
-208
| -12% | -$80.9K | 0.07% | 245 |
|
2025
Q1 | $743K | Sell |
1,709
-72
| -4% | -$31.3K | 0.1% | 208 |
|
2024
Q4 | $657K | Sell |
1,781
-69
| -4% | -$25.4K | 0.09% | 229 |
|
2024
Q3 | $962K | Sell |
1,850
-14
| -0.8% | -$7.28K | 0.13% | 199 |
|
2024
Q2 | $1.01M | Buy |
1,864
+214
| +13% | +$116K | 0.15% | 156 |
|
2024
Q1 | $856K | Sell |
1,650
-427
| -21% | -$221K | 0.13% | 191 |
|
2023
Q4 | $980K | Sell |
2,077
-85
| -4% | -$40.1K | 0.16% | 153 |
|
2023
Q3 | $941K | Sell |
2,162
-1,641
| -43% | -$715K | 0.17% | 139 |
|
2023
Q2 | $1.69M | Buy |
3,803
+101
| +3% | +$44.9K | 0.3% | 83 |
|
2023
Q1 | $1.7M | Buy |
3,702
+177
| +5% | +$81.4K | 0.32% | 85 |
|
2022
Q4 | $1.81M | Buy |
3,525
+1,478
| +72% | +$758K | 0.4% | 71 |
|
2022
Q3 | $930K | Buy |
2,047
+31
| +2% | +$14.1K | 0.23% | 122 |
|
2022
Q2 | $973K | Sell |
2,016
-27
| -1% | -$13K | 0.23% | 126 |
|
2022
Q1 | $1M | Buy |
2,043
+461
| +29% | +$227K | 0.19% | 137 |
|
2021
Q4 | $733K | Hold |
1,582
| – | – | 0.12% | 193 |
|
2021
Q3 | $590K | Hold |
1,582
| – | – | 0.11% | 221 |
|
2021
Q2 | $604K | Buy |
1,582
+530
| +50% | +$202K | 0.11% | 217 |
|
2021
Q1 | $378K | Sell |
1,052
-54
| -5% | -$19.4K | 0.07% | 263 |
|
2020
Q4 | $355K | Buy |
1,106
+138
| +14% | +$44.3K | 0.08% | 252 |
|
2020
Q3 | $260K | Buy |
968
+108
| +13% | +$29K | 0.07% | 262 |
|
2020
Q2 | $226K | Buy |
+860
| New | +$226K | 0.07% | 255 |
|